Daniel Eiger
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- CAR-T cell therapy research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 29
- HER2/EGFR in Cancer Research 18
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 3
-
- Breast Cancer Treatment Studies 10
- Co-authors
- Evandro de Azambuja (20 shared papers)Elisa Agostinetto (3 shared papers)Mariana Brandão (7 shared papers)Rafael Caparica (7 shared papers)Martine Piccart (12 shared papers)Noam Pondé (8 shared papers)Ahmad Awada (4 shared papers)Eleonora Restuccia (8 shared papers)
- Journals
- Annals of Oncology (6 papers)Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)British Journal of Cancer (2 papers)ESMO Open (2 papers)
- Partner nations
- BelgiumBrazilSwitzerland
In The Last Decade
Daniel Eiger
31 papers receiving 590 citations
Peers
Comparison fields: 5 of 66
- Oncology 451
- Cancer Research 128
- Pulmonary and Respiratory Medicine 189
- Radiology, Nuclear Medicine and Imaging 106
- Genetics 43
Countries citing papers authored by Daniel Eiger
This map shows the geographic impact of Daniel Eiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiger more than expected).
Fields of papers citing papers by Daniel Eiger
This network shows the impact of papers produced by Daniel Eiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiger. The network helps show where Daniel Eiger may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Eiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 113 | |
| 2 | 2022 | 82 | |
| 3 | 2019 | 61 | |
| 4 | 2021 | 50 | |
| 5 | 2021 | 32 | |
| 6 | 2018 | 30 | |
| 7 | 2020 | 27 | |
| 8 | 2020 | 24 | |
| 9 | 2020 | 23 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2022 | 11 | |
| 17 | 2020 | 8 | |
| 18 | 2018 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2019 | 4 |
About Daniel Eiger
Daniel Eiger is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 595 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Breast Cancer Treatment Studies (10 papers), Advanced Breast Cancer Therapies (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). The work is most often cited by research in Oncology (451 citations), Cancer Research (128 citations), Pulmonary and Respiratory Medicine (189 citations), Radiology, Nuclear Medicine and Imaging (106 citations) and Genetics (43 citations). Daniel Eiger has collaborated with scholars based in Belgium, Brazil and Switzerland. Frequent co-authors include Evandro de Azambuja, Elisa Agostinetto, Mariana Brandão, Rafael Caparica, Martine Piccart, Noam Pondé, Ahmad Awada, Eleonora Restuccia, Kevin Punie and Maria Alice Franzoi. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, British Journal of Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.